The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Paul Mathew

Department of Genitourinary Medical Oncology

The University of Texas M. D. Anderson Cancer Center

Houston

Texas

USA

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. 2004 - 2009
  • Division of Cancer Medicine, MD Anderson Cancer Centre, Houston, TX 77230-1439, USA. 2006

References

  1. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. Mathew, P., Pisters, L.L., Wood, C.G., Papadopoulos, J.N., Williams, D.L., Thall, P.F., Wen, S., Horne, E., Oborn, C.J., Langley, R., Fidler, I.J., Pettaway, C.A. J. Urol. (2009) [Pubmed]
  2. Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer. Mathew, P., Thall, P.F., Wen, S., Bucana, C., Jones, D., Horne, E., Oh, W.K., Morris, M.J., Lee, Y.C., Logothetis, C.J., Lin, S.H., Fidler, I.J. Br. J. Cancer (2008) [Pubmed]
  3. Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases. Mathew, P., Thall, P.F., Bucana, C.D., Oh, W.K., Morris, M.J., Jones, D.M., Johnson, M.M., Wen, S., Pagliaro, L.C., Tannir, N.M., Tu, S.M., Meluch, A.A., Smith, L., Cohen, L., Kim, S.J., Troncoso, P., Fidler, I.J., Logothetis, C.J. Clin. Cancer Res. (2007) [Pubmed]
  4. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin. Mathew, P., Vakar-Lopez, F., Troncoso, P. Lancet Oncol. (2006) [Pubmed]
  5. Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer. Mathew, P., Logothetis, C.J., Dieringer, P.Y., Chen, I., Pagliaro, L.C., Bekele, B.N., Zhou, X., Daliani, D.D. Clinical. Genitourinary. Cancer (2006) [Pubmed]
  6. Cancer in an incarcerated population. Mathew, P., Elting, L., Cooksley, C., Owen, S., Lin, J. Cancer (2005) [Pubmed]
  7. Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer. Mathew, P., Thall, P.F., Jones, D., Perez, C., Bucana, C., Troncoso, P., Kim, S.J., Fidler, I.J., Logothetis, C. J. Clin. Oncol. (2004) [Pubmed]
 
WikiGenes - Universities